News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

American Regent Introduces Sodium Phosphates Injection, USP; FDA-Approved and "AP" Rated¹ [Yahoo! Finance]

American Regent Introduces Sodium Phosphates Injection, USP; FDA-Approved and "AP" Rated¹

Arbitration Dispute Between Daiichi Sankyo and Seagen Ends [Yahoo! Finance]

Arbitration Dispute Between Daiichi Sankyo and Seagen Ends

Merck, Daiichi lung cancer therapy rejected in U.S. [Seeking Alpha]

Top News Decliners

12/17 Japan shares edge lower on lacklustre export data, profit-taking [Reuters] -5.4%

6/21 FDA declines to approve Daiichi Sankyo's blood cancer treatment [Reuters] -4.6%

4/1 Concert Pharma outlines late-stage CTP-543 trials in Alopecia Areata [Seeking Alpha] -2.7%

12/9 DAIICHI SANKYO/S (OTCMKTS: DSNKY) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock. -2.6%

2/20 Esperion's Multiple Positives, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha] -1.5%

8/12 Daiichi Sankyo, Inc. Appoints Simon King as Chief People Officer across U.S. Divisions -1.1%

1/27 Phase 2 DESTINY-Gastric01 Trial of DS-8201 Versus Chemotherapy Met Primary Endpoint -1.0%

5/14 Precision NanoSystems Signs License Agreement with Daiichi Sankyo for Use of the NanoAssemblr GMP System for Development and Manufacture of Nanomedicines [Canadian Business Journal (Canada)] -0.4%

6/13 Dr. Nicole Saphier: Why Biden's vow to 'cure cancer' if elected received so much backlash [FOX News] -0.3%

8/2 U.S. FDA approves Daiichi Sankyo's treatment for rare joint tumor [Reuters (UK)] -0.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}